Figure 5. Correlation analysis of disulfidptosis-associated lncRNAs (DALs) with diverse clinical characteristics. (A) Heatmap illustrating the correlation between DALs and risk levels, along with various clinical attributes. (B) Age, (C) gender, (D) survival status, (E) staging, (F) T, (G) N, and (H) M distinctions between the high and low-risk cohorts.